Summary of Classification and Labelling
Notified classification and labelling
General Information
602-941-8 |
1-Ethoxy-2,3-difluoro-4-[trans-4-(trans-4-propylcyclohexyl)-cyclohexyl]-benzene |
123560-48-5 |
Notified classification and labelling according to CLP criteria
STOT RE 2 |
H373
(other:Adrenal g...)
(oral)
|
H373
|
|
GHS08 Wng
|
|
|
|
|
1 |
|
View details
|
Number of Aggregated Notifications: 1